Save as PDF
Opens your browser print dialog — select "Save as PDF" to download.
MPH-202T
M.Pharmacy (PCI), II Semester
Examination, June 2025
Advanced Biopharmaceutics & Pharmacokinetics
Time : Three Hours
Maximum Marks : 70
Note: i) Attempt any five questions.
ii) All questions carry equal marks.
a) List out the various mechanisms of drug absorption in the gastrointestinal tract and discuss trancellular transport.
b) Explain the absorption of solutions and suspensions from the gastrointestinal tract.
a) Describe the pharmaceutical factors affecting drug bioavailability.
b) How do the patient-related factors affect bioavailability?
a) Define pharmacokinetic models and explain the one-compartment model for IV infusion administration.
b) Discuss the estimation of Vmax and Kmax parameters and the causes of non-linearity in pharmacokinetics.
a) Explain the purpose of bioavailability studies and discuss pharmacokinetic methods for assessing bioavailability.
b) Discuss the clinical significance of bioequivalence studies.
a) Discuss the pharmacokinetics and pharmacodynamics of biotechnology drugs.
b) Explain the principles of modified-release drug products.
a) Compare the dissolution rate and dissolution process according to the Noyes-Whitney equation.
b) Define In Vitro-In Vivo Correlation (IVIVC) and explain its significance in biopharmaceutics.
a) Describe the compartment modeling for a two-compartment model.
b) Discuss the effect of protein-binding interactions on drug pharmacokinetics.
Write a short note on any two:
a) pH-partition theory of drug absorption
b) Drug product stability
c) Significance of protein binding of drugs
d) Pharmacokinetics of monoclonal antibodies